http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2006130003-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 2005-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2006130003-A |
| titleOfInvention | APPLICATION OF PYRAZOLO [1, 5-A] PYRIMIDIN-7-ILAMINE DERIVATIVES FOR THE TREATMENT OF DISEASES DEPENDING ON PROTEINKINASES |
| abstract | 1. The use of the compounds of formula (I) where R is H, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aliphatic residue, a functional group, or substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted aliphatic residue, which is attached through one linking group or atom to a pyrazolo [1,5-a] pyrimidyl ring; R is H, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted an aliphatic residue, a functional group, or a substituted or unsubstituted aliphatic residue that is attached via a linking group or atom to a pyrazolo [1,5-a] pyrimidyl ring; at least one of R or R represents a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heteroaryl or substituted or unsubstituted aryl, which is attached via a single linking group or atom to the pyrazolo [1,5-a] pyrimidyl ring; A is H, halogen (such as bromine), an aliphatic residue k, a functional group, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and R is H, halogen or lower alkyl or to the use of pharmaceutically acceptable salts of these compounds suitable for the treatment of diseases dependent on protein kinases. 2. The use according to claim 1, wherein R is H, lower alkyl, cycloalkyl, benzyl, benzothienyl, indolyl substituted by lower alkyl, pyridyl or thiazolyl optionally substituted by lower alkyl, unsubstituted phenyl or phenyl substituted by one or two deputies selected from the group |
| priorityDate | 2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 289.